Skip to main content





 Adult Congenital Heart Disease Services (Levels 1 and 2) for people aged 16 and over, Service Specification (CP214). June 2022 (PDF, 423Kb)
 Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (all ages), (PP162) March 2025 (PDF, 236Kb)
 Complex Devices Implantable Cardioverter Defibrillators and Cardiac Resynchronisation Therapy for arrhythmias and heart failure (PP151) March 2025 (PDF, 234Kb)
 Electrophysiology and Ablation Services (16 years and older), Commissioning policy (CP197a) January 2025 (PDF, 347Kb)
 Electrophysiology and Ablation Services (16 years and older), Service Specification (CP197b) January 2025 (PDF, 331Kb)
 Everolimus for the prevention of organ rejection following heart transplantation, Policy Position (PP103), July 2019 (PDF, 164Kb)
 Extra corporeal membrane oxygenation (ECMO) service for adults with cardiac failure, Policy Position Statement, (PP102). July 2019 (PDF, 141Kb)
 Percutaneous Mitral Valve Leaflet repair for primary degenerative mitral regurgitation in adults, Policy Position Statement (PP206). June 2021 (PDF, 476Kb)
 Personalised External Aortic Root Support (PEARS) for surgical management of enlarged aortic root (adults), Policy Position Statement, (PP104). March 2025 (PDF, 195Kb)
 Selexipag for the Treatment of Pulmonary Arterial Hypertension (Adults), Policy Position (PP105), March 2019.pdf (PDF, 255Kb)
 Trans-catheter Aortic Valve Implantation (TAVI) for Severe Symptomatic Aortic Stenosis (SSAS), Commissioning Policy (CP58), March 2019 (PDF, 295Kb)